ФЕТОПЛАЦЕНТАРНЫЙ АНГИОГЕНЕЗ ПРИ НОРМАЛЬНОЙ БЕРЕМЕННОСТИ: РОЛЬ ПЛАЦЕНТАРНОГО ФАКТОРА РОСТА И АНГИОПОЭТИНОВ


Цитировать

Полный текст

Аннотация

В статье представлены данные литературы о роли плацентарного фактора роста и ангиопоэтинов в фетоплацентарном ангиогенезе. Подчеркнута роль рецепторов ангиопоэтинов в формировании сосудистой сети плаценты и соответственно нормальном развитии беременности.

Об авторах

К А ПАВЛОВ

ФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития РФ, Москва

ФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития РФ, Москва

Е А ДУБОВА

ФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития РФ, Москва

ФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития РФ, Москва

А И ЩЕГОЛЕВ

ФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития РФ, Москва

ФГУ Научный центр акушерства, гинекологии и перинатологии им. академика В.И. Кулакова Минздравсоцразвития РФ, Москва

K A Pavlov

Ye A Dubova

A I Shchegolev

Список литературы

  1. Соколян А.В., Мурашко А.В., Кречетова Л.В. и др. Динамика ангиогенных факторов роста во время беременности и в послеродовом периоде у беременных с хронической венозной недостаточностью //Акуш. и гин. - 2009. - № 2. - С. 20-23.
  2. Тютюнник В.Л., Бурлев В.А., Зайдиева З.С. Морфофункциональное состояние системы мать-плацента-плод при плацентарной недостаточности и инфекции // Акуш. и гин. - 2003. - № 6. - С. 11-16.
  3. Achen M.G., Gad J.M., Stacker S.A. et al. Placenta growth factor and vascular endothelial growth factor are coexpressed during early embryonic development // Growth Factors. - 1997. - Vol. 15. - P. 69-80.
  4. Albrecht E.D., Babischkin J.S., Pepe G.J. Regulation of placental villous angiopoietin-1 and -2 expression by estrogen during baboon pregnancy // Mol. Reprod. Dev. - 2008. - Vol. 75. - P. 504-511.
  5. Ali K.Z., Burton G.J., KhalidM.E. et al. Concentrations of free vascular endothelial growth factor in the maternal and foetal circulations during pregnancy: A cross-sectional study // J. Mater. Fet. Neonat. Med. - online on 04 Jan 2010.
  6. Babischkin J.S., Suresch D.L., Pepe G.J. et al. Differential expression of placental villous angiopoietin-1 and -2 during early, mid and late baboon pregnancy // Placenta. - 2007. - Vol. 28. - P. 212-218.
  7. Brown K.J., Maynes S.F., Bezos A. et al. A novel in vitro assay for human angiogenesis // Lab. Invest. - 1996. - Vol. 75. - P. 539-555.
  8. Cao Y., Chen H., Zhou L. et al. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR // J. Biol. Chem. - 1996. - Vol. 271. - P. 3154-3162.
  9. Cao Y., Ji W.R., Qi P. et al. Placenta growth factor: identification and characterization of a novel isoform generated by mRNA alternative splicing // Biochem. Biophys. Res. Commun. - 1997. - Vol. 235. - P. 493-498.
  10. Carmeliet P., Moons L., Luttun A. et al. Synergism between vascular endothelial growth factor and placenta growth factor contributes to angiogenesis and plasma extravasation in pathological conditions // Nat. Med. - 2001. - Vol. 7. - P. 575-583.
  11. Charnock-Jones D.S. Soluble flt and the angiopoietins in the development and regulation of placental vasculature // J. Anat. - 2002. - Vol. 200. - P. 607-615.
  12. Charnock-Jones D.S., Clark D.E., Licence D. et al. Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs // Reproduction. - 2001. - Vol. 122. - P. 753-760.
  13. Clark D.E., Smith S.K., He Y. et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation // Biol. Reprod. - 1998. - Vol. 59. - P. 1540-1548.
  14. Clark D.E., Smith S.K., Sharkey A.M., Charnock- Jones D.S. Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy // Hum. Reprod. - 1996. - Vol. 11. - P. 1090-1098.
  15. Crescimanno C., Marzioni D., Persico M.G. et al. Expression of bFGF, PlGF and their receptors in the human placenta // Placenta. - 1995. - Vol. 16. - P. A.13.
  16. Davis S., Aldrich T.H., Jones P.F. et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning // Dev. Cell. - 1996. - Vol. 87. - P. 1161-1169.
  17. Demir R., Kaufmann P., Erbengi T. Ultrastructural observations on angiogenetic cells formation and differentiation toward vascular endothelium in human placental villi. In: Catravas JD, Callow AD, Ryan US, editors. Vascular endothelium: physiological basis of clinical problems I. - New York-London: Plenum Press, 1992. - P. 240-242.
  18. Demir R., Kayisli U.A., Seval Y. et al. Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis // Placenta. - 2004. - Vol. 25. - P. 560-572.
  19. Dunk C., Shams M., Nijjar S. et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development // Amer. J. Pathol. - 2000. - Vol. 156. - P. 2185-2199.
  20. Eklund L., Olsen B.R. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling // Exp. Cell. Res. - 2006. - Vol. 312. - P. 630-641.
  21. Gale N.W., Thurston G., Hackett S.F. et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1 // Dev. Cell. - 2002. - Vol. 3. - P. 411-423.
  22. Geva E., Ginzinger D.G., Zaloudek C.J. et al. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2 // J. Clin. Endocrinol. Metab. - 2002. - Vol. 87. - P. 4213-4224.
  23. Ghosh D., Sharkey A.M., Charnock-Jones D.S. et al. Expression of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in conceptus and endometrium during implantation in the rhesus monkey // Mol. Hum. Reprod. - 2000. - Vol. 6. - P. 935-941.
  24. Goldman-Wohl D.S., Ariel I., Greenfield C. et al. Tie-2 and angiopoietin-2 expression at the fetale maternal interface: a receptor ligand model for vascular remodelling // Mol. Hum. Reprod. - 2000. - Vol. 6. - P. 81-87.
  25. Huang X.L., Takakura N., Suda T. In vitro effects of angiopoietins and VEGF on hematopoietic and endothelial cells // Biochem. Biophys. Res. Commun. - 1999. - Vol. 264. - P. 133-138.
  26. Kayisli U. A., Cayli S., Seval Y. et al. Spatial and temporal distribution of Tie-1 and Tie-2 during very early development of the human placenta // Placenta. - 2006. - Vol. 27. - P. 648-659.
  27. Khaliq A., Dunk C., Jiang J. et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction // Lab. Invest. - 1999. - Vol. 79. - P. 151-170.
  28. Khaliq A., Li X.F., Shams M. et al. Localization of placenta growth factor (PlGF) in human term placenta // Growth Factors. - 1996. - Vol. 13. - P. 243-250.
  29. Korhonen J., Partanen J., Armstrong E. et al. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization // Blood. - 1992. - Vol. 80. - P. 2548-2555.
  30. Kumazaki K., Nakayama M., Suehara N., Wada Y. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions // Hum. Pathol. - 2002. - Vol. 33. - P. 1069-1077.
  31. Lang I., Pabst M.A., Hiden U. et al. Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells // Eur. J. Cell. Biol. - 2003. - Vol. 82. - P. 163-173.
  32. Lijnen H.R., Christiaens V., Scroyen I. et al. Impaired adipose tissue development in mice with inactivation of placental growth factor function // Diabetes. - 2006. - Vol. 5. - P. 2698-2704.
  33. LuttunA., TjwaM., MoonsL. et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 // Nat. Med. - 2002. - Vol. 8. - P. 831-840.
  34. Maglione D., Guerriero V., Viglietto G. et al. Isolation of human placenta cDNA coding for a protein related to the vascular permeability factor // Proc. Natl. Acad. Sci. USA. - 1991. - Vol. 88. - P. 9267-9271.
  35. Maglione D., Guerriero V., Viglietto G. et al. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14 // Oncogene. - 1993. - Vol. 8. - P. 925- 931.
  36. Maisonpierre P.C., Suri C., Jones P.F. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis // Science. - 1997. - Vol. 277. - P. 55-60.
  37. Miao H.Q., Soker S., Feiner L. et al. Neuropilin-1 mediates collapsin-1/ semaphorin III inhibition of endothelial cell motility: functional competion of collapsin-1 and vascular endothelial growth factor-165 // J. Cell. Biol. - 1999. - Vol. 146. - P. 233-242.
  38. MigdalM., Huppertz B., Tessler S. et al. Neuropilin-1 is a placenta growth factor-2 receptor // J. Biol. Chem. - 1998. - Vol. 273. - P. 22272- 22278.
  39. Odorisio T., Schietroma C., Zaccaria M.L. et al. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability // J. Cell. Sci. - 2002. - Vol. 115. - P. 2559-2567.
  40. Partanen J., Dumont D. Functions of Tie1 and Tie2 receptor tyrosine kinases in vascular development. - Berlin: Springer-Verlag, 1999.
  41. Persico M.G., Vincenti V., Di Palma T. Structure, expression and receptor-binding properties of placenta growth factor (PlGF) // Curr. Top. Microbiol. Immunol. - 1999. - Vol. 237. - P. 31-40.
  42. Ribatti D. The discovery of the placental growth factor and its role in angiogenesis: a historical review // Angiogenesis. - 2008. - Vol. 11. - P. 215-221.
  43. Sato T.N., Tozawa Y., Deutsch U. et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation // Nature. - 1995. - Vol. 376. - P. 70-74.
  44. Seval Y., Korgun E.T., Demir R. Hofbauer cells in early human placenta: possible implications in vasculogenesis and angiogenesis // Placenta. - 2007. - Vol. 28. - P. 841-845.
  45. Seval Y., Sati L., Celik-Ozenci C. et al. The distribution of angiopoietin-1, angiopoietin-2 and their receptors tie-1 and tie-2 in the very early human placenta // Placenta. - 2008. - Vol. 29. - P. 809-815.
  46. Shiraishi S., Nakagawa K., Kinukawa N. et al. Immunohistochemical localization of vascular endothelial growth factor in the human placenta // Placenta. - 1996. - Vol. 17. - P. 111- 121.
  47. Shore V.H., Wang T-H., Wang C-L. et al. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast // Placenta. - 1997. - Vol. 18. - P. 657-665.
  48. Suri C., McClain J., Thurston G. et al. Increased vascularization in mice overexpressing angiopoietin-1 // Science. - 1998. - Vol. 282. - P. 468-471.
  49. Visconti R.P., Richardson C.D., Sato T.N. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF) // Proc. Natl. Acad. Sci. USA. - 2002. - Vol. 99. - P. 8219-8224.
  50. Voros G., Maquoi E., Demeuelemeester D. et al. Modulation of angiogenesis during adipose tissue development in murine models of obesity // Endocrinology. - 2005. - Vol. 146. - P. 4545-4554.
  51. Vuckovic M., Ponting J., Terman B.I. et al. Expression of the vascular endothelial growthfactor receptor, KDR, in human placenta // J. Anat. - 1996. - Vol. 188. - P. 361-366.
  52. Vuorela P., Carpen O., Tulppala M. et al. VEGF, its receptors and the tie receptors in recurrent miscarriage // Mol. Hum. Reprod. - 2000. - Vol. 6. - P. 276-282.
  53. Vuorela P., Hatva E., Lymboussaki A. et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta // Biol. Reprod. - 1997. - Vol. 56. - P. 489- 494.
  54. Ward N.L., Dumont D.J. The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development // Semin. Cell Dev. Biol. - 2002. - Vol. 13. - P. 19-27.
  55. Witzenbichler B., Maisonpierre P.C., Jones P. et al. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2 // J. Biol. Chem. - 1998. - Vol. 273. - P. 18514-18521.
  56. Wulff C., Wilson H., Dickson S.E. et al. Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy // Biol. Reprod. - 2002. - Vol. 66. - P. 802-812.
  57. Yang W., Ahm H., Hinrichs M. et al. Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human throphoblast and endothelial cells // J. Reprod. Immunol. - 2003. - Vol. 60. - P. 53-60.
  58. Yuan H.T., Venkatesha S., Chan B. et al. Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival // Faseb. J. - 2007. - Vol. 21. - P. 3171-3183.
  59. Ziche M., Maglione D., Ribatti D. et al. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic // Lab. Invest. - 1997. - Vol. 76. - P. 517-531.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах